#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Warm autoimmune haemolytic anaemia Chronic myelomonocytic leukaemia Oropharyngeal cancer recurrent Human papilloma virus immunisation Follicular lymphoma Aspergillus infection Cutaneous T-cell lymphoma Squamous cell carcinoma of the cervix Skin angiosarcoma Antisynthetase syndrome Chronic graft versus host disease in skin Arginase deficiency Glycogen storage disease type V Polycythaemia vera Prodromal Alzheimer's disease More trials…

    Learn about Rare Diseases

    Medulloblastoma Progressive multifocal leukoencephalopathy – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Idiopathic pulmonary fibrosis – Treatment Retinoblastoma – Treatment Small intestine leiomyosarcoma – Treatment Pemphigus – Trials in Disease Haemophilia A with anti factor VIII Ewing’s sarcoma recurrent – Treatment Toxic epidermal necrolysis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Human Vaccinia Immunoglobulin Coffee Charcoal Amitriptyline Hydrochloride Ngm707 SODIUM BENZOATE TRV045 Englumafusp Alfa Ondansetron Hydrochloride Demeclocycline Hydrochloride Hydralazine Hydrochloride SALICYLIC ACID Budesonide Melatonin Tasquinimod Vinblastine Sulfate 18F-Fludarabine Deferoxamine Mesilate Fostemsavir Liraglutide Fasudil Hydrochloride More therapies…

    Learn about Your Condition

    Varices oesophageal Multiple sclerosis Penile squamous cell carcinoma Cerebrovascular accident Mastocytosis Heart disease congenital Hypervolaemia Decreased appetite Cirrhosis alcoholic Arterial disorder Synovial sarcoma Labour induction Fibrous dysplasia of bone Peripheral artery thrombosis Bladder cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

B-cell lymphoma

  • A study comparing AZD0486 after reduced chemotherapy versus standard chemotherapy in older or unfit patients with newly diagnosed large B-cell lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Belgium Poland
  • A Study of Allo-QuadCAR01-T Cell Therapy for Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • ALLO-QUADCAR01-T
    Germany
  • Study of LUMC-BOB1-B7-TCR.

    Recruiting

    2 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • B-cell type acute leukaemia
    • Plasma cell myeloma
    Investigated Drugs:
    • LUMC-BOB1-B7-TCR.1
    The Netherlands
  • Study on Immunotherapy with HSP-CAR19M and Drug Combination for Adults with B-cell Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    • Mantle cell lymphoma
    • B-cell lymphoma
    Investigated Drugs:
    • HSP-CAR19M
    • Bendamustine Hydrochloride
    • Cyclophosphamide Monohydrate
    Spain
  • Study of IDP-121 for Patients with Relapsed or Refractory Multiple Myeloma, B-cell Lymphoma, or Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • Chronic lymphocytic leukaemia
    • Plasma cell myeloma
    Investigated Drugs:
    • IDP-121
    Spain
  • Study of valemetostat tosylate tablets in patients with relapsed or refractory B-cell lymphoma, including aggressive B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Hodgkin lymphoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • B-cell lymphoma
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Valemetostat Tosilate
    Belgium France
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!